Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

SELL
$0.56 - $1.24 $1.6 Million - $3.54 Million
-2,852,884 Reduced 89.19%
345,861 $252,000
Q4 2022

Feb 09, 2023

SELL
$0.83 - $2.26 $375,441 - $1.02 Million
-452,339 Reduced 12.39%
3,198,745 $3.39 Million
Q3 2022

Nov 02, 2022

BUY
$1.93 - $3.14 $142,574 - $231,961
73,873 Added 2.07%
3,651,084 $8.11 Million
Q2 2022

Aug 01, 2022

SELL
$1.69 - $3.26 $34,793 - $67,116
-20,588 Reduced 0.57%
3,577,211 $7.3 Million
Q1 2022

May 04, 2022

BUY
$2.99 - $4.19 $815,519 - $1.14 Million
272,749 Added 8.2%
3,597,799 $11.3 Million
Q4 2021

Feb 07, 2022

BUY
$3.77 - $6.99 $583,788 - $1.08 Million
154,851 Added 4.88%
3,325,050 $12.5 Million
Q3 2021

Nov 02, 2021

BUY
$4.84 - $6.91 $1.32 Million - $1.89 Million
273,324 Added 9.44%
3,170,199 $21.6 Million
Q2 2021

Aug 03, 2021

BUY
$5.11 - $7.64 $143,166 - $214,049
28,017 Added 0.98%
2,896,875 $17.1 Million
Q1 2021

May 04, 2021

BUY
$5.03 - $10.5 $3.16 Million - $6.61 Million
629,123 Added 28.09%
2,868,858 $20.5 Million
Q4 2020

Feb 01, 2021

SELL
$3.48 - $6.58 $398,717 - $753,896
-114,574 Reduced 4.87%
2,239,735 $12 Million
Q3 2020

Nov 09, 2020

BUY
$2.78 - $26.5 $1.74 Million - $16.6 Million
625,788 Added 36.2%
2,354,309 $13.6 Million
Q2 2020

Aug 07, 2020

SELL
$2.34 - $3.53 $1.1 Million - $1.66 Million
-469,517 Reduced 21.36%
1,728,521 $5.1 Million
Q1 2020

May 04, 2020

SELL
$2.3 - $5.5 $82,077 - $196,273
-35,686 Reduced 1.6%
2,198,038 $5.96 Million
Q4 2019

Feb 06, 2020

SELL
$3.0 - $5.0 $34,797 - $57,995
-11,599 Reduced 0.52%
2,233,724 $7.55 Million
Q4 2019

Feb 04, 2020

BUY
$3.0 - $5.0 $528,270 - $880,450
176,090 Added 8.51%
2,245,323 $10.3 Million
Q3 2019

Nov 12, 2019

BUY
$3.31 - $5.6 $1.99 Million - $3.36 Million
600,506 Added 40.89%
2,069,233 $7.86 Million
Q2 2019

Aug 15, 2019

BUY
$5.28 - $8.2 $767,426 - $1.19 Million
145,346 Added 10.98%
1,468,727 $8.31 Million
Q1 2019

May 03, 2019

BUY
$5.84 - $12.02 $530,225 - $1.09 Million
90,792 Added 7.37%
1,323,381 $10.6 Million
Q4 2018

Feb 05, 2019

BUY
$6.32 - $19.44 $7.79 Million - $24 Million
1,232,589 New
1,232,589 $10.1 Million

Others Institutions Holding EQ

About Equillium, Inc.


  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $47.1M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.